Market Indices


Latest News

from CLSA issued a price target of $6.10 for

June 5, 2026   MLCO -1.12%

CLSA analyst issues HOLD recommendation for MLCO on June 5,...

June 5, 2026   MLCO -1.12%

Cowen & Co. analyst issues HOLD recommendation for EQNR on...

June 5, 2026   EQNR -0.64%

UBS analyst issues POSITIVE recommendation for JP on June 5,...

June 5, 2026   EQNR -0.64%

Bernstein analyst issues OUTPERFORM recommendation for BZ on June 5,...

June 5, 2026   BZ 0.46%


Price Targets

from CLSA issued a price target of $6.10 for MLCO on 2026-06-05 13:29:13.The adjusted price target was set to $6.10.At the time of the announcement, MLCO was...

June 5, 2026   MLCO -1.12%

from UBS issued a price target of $10.00 for MOMO on 2026-06-04 13:24:00.The adjusted price target was set to $10.00.At the time of the announcement, MOMO was...

June 4, 2026   MOMO -2.03%

Douglas Tsao from H.C. Wainwright issued a price target of $940.00 for ARGX on 2026-06-04 10:40:00.The adjusted price target was set to $940.00.At the time of the announcement,

June 4, 2026   ARGX 4.30%

Wei Shen from UBS issued a price target of $11.10 for EH on 2026-06-04 08:59:04.The adjusted price target was set to $11.10.At the time of the announcement, EH...

June 4, 2026   EH -12.13%

Jonathan Chang from Leerink Partners issued a price target of $46.00 for NBTX on 2026-06-04 08:02:00.The adjusted price target was set to $46.00.At the time of the announcement,

June 4, 2026   NBTX -3.87%



Market Movers

Top Gainers (%)
NA
Nano Labs Ltd
2.21
10.25%
AIXI
Xiao-I Corporation
9.41
9.55%
BQ
Boqii Holding Limited
0.78
8.33%
STG
Sunlands Technology Group
3.60
5.62%
ACH
Accendra Health, Inc.
2.80
5.47%
YI
111, Inc.
4.96
4.98%
QNRX
Quoin Pharmaceuticals, Lt
4.49
4.66%
ARGX
argenx SE
878.50
4.30%

Annual/Quarterly Reports Summary

In a landscape marked by financial fluctuations, the company reported a rise in other income but faced significant operating expenses, leading to a net loss. Management is focused on building...

May 1, 2025   SMMT -0.61%

In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...

February 5, 2025   TEVA 1.19%

In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...

January 27, 2025   TEVA 1.19%